Document is current
Any future updates will be listed below
-
Authors
Li, Bowen
Manan, Rajith Singh https://orcid.org/0000-0001-7081-0138
Liang, Shun-Qing https://orcid.org/0000-0003-4664-6029
Gordon, Akiva https://orcid.org/0000-0002-6679-2974
Jiang, Allen https://orcid.org/0000-0002-9826-5976
Varley, Andrew
Gao, Guangping https://orcid.org/0000-0003-0097-9012
Langer, Robert https://orcid.org/0000-0003-4255-0492
Xue, Wen https://orcid.org/0000-0002-9797-8042
Anderson, Daniel https://orcid.org/0000-0001-5629-4798
- License Information
-
More Information
Article History
Received: 21 July 2022
Accepted: 18 January 2023
First Online: 30 March 2023
Competing interests
: B.L., R.S.M., A.G. and D.A. have filed a patent (PCT/US2022/052314) for development of the described lipids. D.A. receives research funding from Translate Bio and is a Founder of Orna Therapeutics. R.L. is a cofounder of Moderna; he also serves on the board and has equity in Particles for Humanity. For a list of entities with which R.L. is, or has been, recently involved, compensated or uncompensated, see . The other authors declare no competing interests.
